Work

Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

Year: 2025

Type: article

Source: Blood

DOI: 10.1182/blood.2024027674

Authors: Smith Giri, Binod Dhakal, Natalie S. Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai R. Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano Costa

Institutions: University of Alabama at Birmingham, UAB Medicine, Medical College of Wisconsin, University of Wisconsin System, University of Wisconsin–Madison, Oregon Health & Science University, OHSU Knight Cancer Institute, Vanderbilt University, Vanderbilt University Medical Center, Mayo Clinic in Arizona

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409230652

FWCI: 13.73

Cites: 23

Cited by: 21

Related to: 10